CEFDINIR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefdinir, and what generic alternatives are available?
Cefdinir is a drug marketed by Alkem Labs Ltd, Anda Repository, Aurobindo Pharma, Lupin, Sandoz, and Teva Pharms. and is included in twelve NDAs.
The generic ingredient in CEFDINIR is cefdinir. There are twelve drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the cefdinir profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefdinir
A generic version of CEFDINIR was approved as cefdinir by LUPIN on May 19th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFDINIR?
- What are the global sales for CEFDINIR?
- What is Average Wholesale Price for CEFDINIR?
Summary for CEFDINIR
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 28 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Clinical Trials: | 27 |
| Patent Applications: | 4,966 |
| Drug Prices: | Drug price information for CEFDINIR |
| Drug Sales Revenues: | Drug sales revenues for CEFDINIR |
| DailyMed Link: | CEFDINIR at DailyMed |
Recent Clinical Trials for CEFDINIR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assistance Publique - Hôpitaux de Paris | Phase 4 |
| Northeast Ohio Medical University | Phase 2 |
| Mercy Health Ohio | Phase 2 |
Pharmacology for CEFDINIR
| Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFDINIR
US Patents and Regulatory Information for CEFDINIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | CEFDINIR | cefdinir | CAPSULE;ORAL | 210220-001 | Feb 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms | CEFDINIR | cefdinir | FOR SUSPENSION;ORAL | 065332-002 | May 4, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | CEFDINIR | cefdinir | FOR SUSPENSION;ORAL | 210534-001 | Feb 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lupin | CEFDINIR | cefdinir | CAPSULE;ORAL | 065264-001 | May 19, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
